Journal article · 2009

Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells

Federica Ferrigno, Danila Branca, Olaf D. Kinzel, Samuele Lillini, Laura Llauger Bufi, Edith S. Monteagudo, Ester Muraglia, Michael Rowley, Carsten Schultz‐Fademrecht, Carlo Toniatti, Caterina Torrisi, PHILIP G. JONES

Bioorganic & Medicinal Chemistry Letters, 20(3), 1100–1105 · Published 24 November 2009 · DOI 10.1016/j.bmcl.2009.11.087

View at the publisherCite this paper

In brief

“Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells” is a 2009 journal article by Federica Ferrigno and 11 co-authors, published in Bioorganic & Medicinal Chemistry Letters. OpenAlex counts 19 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
19
Most cited in
2024 (4)
Field-weighted impact
0.35
References
13
Authors
12

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ferrigno, F., Branca, D., Kinzel, O. D., Lillini, S., Bufi, L. L., Monteagudo, E. S., Muraglia, E., Rowley, M., Schultz‐Fademrecht, C., Toniatti, C., Torrisi, C., & JONES, P. G. (2009). Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells. Bioorganic & Medicinal Chemistry Letters, 20(3), 1100–1105. https://doi.org/10.1016/j.bmcl.2009.11.087

MLA 9

Ferrigno, Federica, et al. “Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells.” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 3, 2009, pp. 1100–1105. https://doi.org/10.1016/j.bmcl.2009.11.087.

Chicago

Ferrigno, Federica, Danila Branca, Olaf D. Kinzel, Samuele Lillini, Laura Llauger Bufi, Edith S. Monteagudo, Ester Muraglia, et al. 2009. “Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells.” Bioorganic & Medicinal Chemistry Letters 20 (3): 1100–1105. https://doi.org/10.1016/j.bmcl.2009.11.087.

Harvard

Ferrigno, F. et al. (2009) ‘Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells’, Bioorganic & Medicinal Chemistry Letters, 20(3), pp. 1100–1105. doi:10.1016/j.bmcl.2009.11.087.

IEEE

F. Ferrigno et al., “Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 3, pp. 1100–1105, 2009, doi: 10.1016/j.bmcl.2009.11.087.

BibTeX

@article{ferrigno2009development,
  title     = {{Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells}},
  author    = {Ferrigno, Federica and Branca, Danila and Kinzel, Olaf D. and Lillini, Samuele and Bufi, Laura Llauger and Monteagudo, Edith S. and Muraglia, Ester and Rowley, Michael and Schultz‐Fademrecht, Carsten and Toniatti, Carlo and Torrisi, Caterina and JONES, PHILIP G.},
  journal   = {Bioorganic \& Medicinal Chemistry Letters},
  year      = {2009},
  volume    = {20},
  number    = {3},
  pages     = {1100--1105},
  doi       = {10.1016/j.bmcl.2009.11.087},
  url       = {https://doi.org/10.1016/j.bmcl.2009.11.087}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201211
201322
201433
201511
201622
202011
202211
202322
202444
202511

Its field-weighted citation impact is 0.35: it has been cited 0.35 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy

  • PARP-1 inhibitors
  • pyridazinone derivatives
  • structure-activity relationship
  • anticancer agents
  • hERG selectivity
  • cytochrome P450 inhibition
  • drug metabolism
  • pharmacokinetics

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Ferrigno, F., Branca, D., Kinzel, O. D., Lillini, S., Bufi, L. L., Monteagudo, E. S., Muraglia, E., Rowley, M., Schultz‐Fademrecht, C., Toniatti, C., Torrisi, C., & JONES, P. G. (2009). Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells. Bioorganic & Medicinal Chemistry Letters, 20(3), 1100–1105. https://doi.org/10.1016/j.bmcl.2009.11.087

How many times has this paper been cited?

19 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Federica Ferrigno, Danila Branca, Olaf D. Kinzel, Samuele Lillini, Laura Llauger Bufi, Edith S. Monteagudo, Ester Muraglia, Michael Rowley, Carsten Schultz‐Fademrecht, Carlo Toniatti, Caterina Torrisi, PHILIP G. JONES.

What is the DOI of this paper?

10.1016/j.bmcl.2009.11.087, permanently at https://doi.org/10.1016/j.bmcl.2009.11.087. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.